CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Advancing Generic Drug Development: Leveraging Model-Integrated Evidence (MIE) in the Development & Approval of Generic Drugs - 08/27/2026

ConferenceNeutral
AI Analysis

Summary

FDA Drugs is hosting a half-day workshop on August 27, 2026, featuring expert presentations on Model-Integrated Evidence (MIE) in generic drug development and approval. The event will include audience Q&A sessions on regulatory considerations in this evolving field.

Importance:2/10
Sentiment:
0.00
generic drugsregulatoryModel-Integrated EvidenceworkshopFDA

Read the original article

Published by FDA Drugs (New Approvals & NDA) on August 10, 2026 2:43 PM

Read Original